AnaptysBio, Inc. (ANAB)
USD 17.48
(-5.59%)
USD 17.48
(-5.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -120.8 Million | -73.59 Million | -45.92 Million | -14.15 Million | -69.51 Million | -48.5 Million |
| Net Income | -163.61 Million | -128.72 Million | -57.79 Million | -19.93 Million | -97.33 Million | -61.65 Million |
| Depreciation & Amortization | 2.37 Million | 2.33 Million | 2.09 Million | 559 Thousand | 514 Thousand | 315 Thousand |
| Deferred income taxes | -10.93 Million | - | 478 Thousand | - | -2.63 Million | -1.23 Million |
| Stock-based compensation | 33.2 Million | 27.35 Million | 15.34 Million | 11.49 Million | 12.41 Million | 9.96 Million |
| Change in working capital | -324 Thousand | 6.83 Million | -7.48 Million | -6.77 Million | 16.85 Million | 3.46 Million |
| Other non-cash items | 18.5 Million | 18.6 Million | 1.45 Million | 487 Thousand | 676 Thousand | 646 Thousand |
| Investing Cash Flow | 144.75 Million | -394.84 Million | 38.83 Million | 94.47 Million | 131.43 Million | -142.45 Million |
| Investments in PPE | -807 Thousand | -358 Thousand | -1.36 Million | -569 Thousand | -805 Thousand | -1.06 Million |
| Acquisitions | -145.56 Million | 394.48 Million | 15 Thousand | 194.92 Million | 251.81 Million | 347.53 Million |
| Investment purchases | -303.91 Million | -802.5 Million | -118.66 Million | -194.92 Million | -251.81 Million | -347.53 Million |
| Sales/Maturities of investments | 449.48 Million | 408.01 Million | 158.84 Million | 289.97 Million | 384.05 Million | 206.14 Million |
| Other Investing Activities | 145.56 Million | -394.48 Million | 40.2 Million | -194.92 Million | -251.81 Million | -347.53 Million |
| Financing Cash Flow | -59.29 Million | 44.01 Million | 252.29 Million | -879 Thousand | -4.49 Million | 223.36 Million |
| Debt repayment | -11.72 Million | -30.68 Million | -72 Thousand | -1.37 Million | -7.5 Million | -6.87 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -50 Million | - | - | - | - | - |
| Common Stock Issuance | 2.47 Million | 11.82 Million | 2.55 Million | 496 Thousand | 3 Million | 227.47 Million |
| Other Financing Activities | 11.68 Million | 62.87 Million | 249.81 Million | -879 Thousand | -4.49 Million | 2.76 Million |
| Accounts receivables | -5.43 Million | -543 Thousand | -876 Thousand | - | 174 Thousand | 1.42 Million |
| Accounts payables | 10.93 Million | 9.7 Million | -4.74 Million | -8.87 Million | 14.49 Million | 7.08 Million |
| Inventory | 5.1 Million | - | - | - | -174 Thousand | - |
| Other working capital | -10.93 Million | -2.31 Million | -1.87 Million | 2.1 Million | 2.35 Million | -3.62 Million |
| Cash at beginning of period | 71.3 Million | 495.72 Million | 250.51 Million | 171.07 Million | 113.65 Million | 81.24 Million |
| Cash at end of period | 35.96 Million | 71.3 Million | 495.72 Million | 250.51 Million | 171.07 Million | 113.65 Million |
| Capital Expenditure | -807 Thousand | -358 Thousand | -1.36 Million | -569 Thousand | -805 Thousand | -1.06 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -35.34 Million | -424.42 Million | 245.21 Million | 79.43 Million | 57.42 Million | 32.4 Million |
| Free Cash Flow | -121.6 Million | -73.95 Million | -47.28 Million | -14.72 Million | -70.32 Million | -49.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.85 Million | -46.66 Million | -43.93 Million | -163.61 Million | -42.21 Million | -37.3 Million |
| Depreciation & Amortization | 596 Thousand | 595 Thousand | 605 Thousand | 2.37 Million | 604 Thousand | 592 Thousand |
| Deferred income taxes | - | - | - | -10.93 Million | -3.15 Million | -2.99 Million |
| Stock-based compensation | 8.18 Million | 7.54 Million | 10.13 Million | 33.2 Million | 8.11 Million | 7.8 Million |
| Change in working capital | -1.32 Million | 8.72 Million | -7.4 Million | -324 Thousand | -2.65 Million | -9 Million |
| Other non-cash items | 15.29 Million | 18.05 Million | 13.16 Million | 18.5 Million | 4.95 Million | 4.43 Million |
| Investing Cash Flow | 58.62 Million | -2.44 Million | 68.61 Million | 144.75 Million | 49.17 Million | 30.63 Million |
| Investments in PPE | -35 Thousand | -33 Thousand | -27 Thousand | -807 Thousand | -280 Thousand | -162 Thousand |
| Acquisitions | - | - | - | -145.56 Million | -49.45 Million | -30.79 Million |
| Investment purchases | -51.34 Million | -149.15 Million | -58.99 Million | -303.91 Million | -66.3 Million | -70.04 Million |
| Sales/Maturities of investments | 110 Million | 146.74 Million | 127.64 Million | 449.48 Million | 115.76 Million | 100.84 Million |
| Other Investing Activities | - | -2.4 Million | 68.64 Million | 145.56 Million | 49.45 Million | 30.79 Million |
| Financing Cash Flow | 71.23 Million | 34.95 Million | -6.69 Million | -59.29 Million | -5.15 Million | -3.07 Million |
| Debt repayment | -33.97 Million | -33.97 Million | - | -11.72 Million | -5.42 Million | -2.43 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -50 Million | - | - |
| Common Stock Issuance | 4.12 Million | 979 Thousand | 811 Thousand | 2.47 Million | 264 Thousand | 160 Thousand |
| Other Financing Activities | 101.07 Million | 40.91 Million | -7.5 Million | 11.68 Million | -5.42 Million | -798 Thousand |
| Accounts receivables | 2.15 Million | -1.91 Million | -238 Thousand | -5.43 Million | -3.58 Million | -87 Thousand |
| Accounts payables | 3.36 Million | 8.01 Million | -5.17 Million | 10.93 Million | -1.49 Million | -2.7 Million |
| Inventory | - | - | - | 5.1 Million | - | - |
| Other working capital | -631 Thousand | 2.62 Million | -1.99 Million | -10.93 Million | 2.42 Million | -6.21 Million |
| Cash at beginning of period | 71.82 Million | 53.69 Million | 35.96 Million | 71.3 Million | 26.29 Million | 35.2 Million |
| Cash at end of period | 191.58 Million | 71.82 Million | 53.69 Million | 35.96 Million | 35.96 Million | 26.29 Million |
| Capital Expenditure | -35 Thousand | -33 Thousand | -27 Thousand | -807 Thousand | -280 Thousand | -162 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 119.76 Million | 18.12 Million | 17.73 Million | -35.34 Million | 9.67 Million | -8.91 Million |
| Free Cash Flow | -10.12 Million | -14.41 Million | -44.22 Million | -121.6 Million | -34.62 Million | -36.63 Million |
SMGI
MELE
PFC
LMTI
3184
GFM